147 related articles for article (PubMed ID: 32035861)
1. Primary pseudomyogenic hemangioendothelioma of right maxilla: a case with immunohistochemistry and FOSB rearrangement study.
Xia RH; Zhu L; Wang LZ; Tian Z; Zhang CY; Hu YH; Gu T; Li J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):e96-e105. PubMed ID: 32035861
[TBL] [Abstract][Full Text] [Related]
2. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
3. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
5. Primary pseudomyogenic hemangioendothelioma of bone: case report and review of the literature.
Squillaci S; Pitino A; Spairani C; Rassu PC; Chiapuzzo E; Kutzner H
Pathologica; 2018 Sep; 110(2):96-101. PubMed ID: 30546145
[TBL] [Abstract][Full Text] [Related]
6. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone.
Bridge JA; Sumegi J; Royce T; Baker M; Linos K
Genes Chromosomes Cancer; 2021 Jan; 60(1):38-42. PubMed ID: 32749039
[TBL] [Abstract][Full Text] [Related]
7. Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR--report of a case.
Ide YH; Tsukamoto Y; Ito T; Watanabe T; Nakagawa N; Haneda T; Nagai M; Yamanishi K; Hirota S
Pathol Res Pract; 2015 May; 211(5):415-20. PubMed ID: 25749627
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological study of pseudomyogenic hemangioendothelioma.
Yang N; Huang Y; Yang P; Yan W; Zhang S; Li N; Feng Z
Diagn Pathol; 2023 Feb; 18(1):25. PubMed ID: 36803395
[TBL] [Abstract][Full Text] [Related]
9. Pseudomyogenic Hemangioendothelioma: A Vascular Tumor Previously Undescribed in the Oral Cavity.
Rawal YB; Anderson KM; Dodson TB
Head Neck Pathol; 2017 Dec; 11(4):525-530. PubMed ID: 27878449
[TBL] [Abstract][Full Text] [Related]
10. Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case.
Fan C; Yang L; Lin X; Wang E
Diagn Pathol; 2015 Aug; 10():150. PubMed ID: 26315812
[TBL] [Abstract][Full Text] [Related]
11. Two Cases of Intraosseous Pseudomyogenic (Epithelioid Sarcoma-Like) Hemangioendothelioma With Unusual Features, Expanding the Clinicopathological Spectrum.
Rekhi B; Rane S; Puri A
Int J Surg Pathol; 2021 Jun; 29(4):454-461. PubMed ID: 32851904
[TBL] [Abstract][Full Text] [Related]
12. Molecularly Confirmed Pseudomyogenic Hemangioendothelioma with Unusual EGFL7::FOSB Fusion in the Head and Neck Region of an Older Patient.
Ren D; Lou J; Wei K; Ifegwu I
Diagnostics (Basel); 2024 Feb; 14(3):. PubMed ID: 38337858
[TBL] [Abstract][Full Text] [Related]
13. A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature.
Ge Y; Lin X; Zhang F; Xu F; Luo L; Huang W; Liu Z; Liu Y; Li Z
Diagn Pathol; 2019 Jul; 14(1):79. PubMed ID: 31311568
[TBL] [Abstract][Full Text] [Related]
14. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.
Pradhan D; Schoedel K; McGough RL; Ranganathan S; Rao UNM
Hum Pathol; 2018 Jan; 71():126-134. PubMed ID: 29104110
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions.
Agaram NP; Zhang L; Cotzia P; Antonescu CR
Am J Surg Pathol; 2018 Dec; 42(12):1653-1661. PubMed ID: 30256258
[TBL] [Abstract][Full Text] [Related]
16. Primary Pseudomyogenic Hemangioendothelioma of Bone.
Inyang A; Mertens F; Puls F; Sumathi V; Inwards C; Folpe A; Lee CH; Zhang Y; Symmans P; Rubin B; Nielsen GP; Nguyen VH; Rosenberg AE
Am J Surg Pathol; 2016 May; 40(5):587-98. PubMed ID: 26872012
[TBL] [Abstract][Full Text] [Related]
17. Pseudomyogenic Hemangioendothelioma: A Case of a Solitary Lesion With a Very Indolent Clinical Course.
Gant T; Bui CM; Brien E; Balzer B
Cureus; 2022 Dec; 14(12):e33172. PubMed ID: 36726928
[TBL] [Abstract][Full Text] [Related]
18. [Epithelioid sarcoma-like hemangioendothelioma: a clinicopathologic and immunohistochemical study of 3 cases].
Cai JN; Peng F; Li LX; Cheng YF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):27-31. PubMed ID: 21429355
[TBL] [Abstract][Full Text] [Related]
19. Fusion of the Genes
Panagopoulos I; Lobmaier I; Gorunova L; Heim S
Cancer Genomics Proteomics; 2019; 16(4):293-298. PubMed ID: 31243110
[TBL] [Abstract][Full Text] [Related]
20. Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.
van IJzendoorn DGP; Sleijfer S; Gelderblom H; Eskens FALM; van Leenders GJLH; Szuhai K; Bovée JVMG
Clin Cancer Res; 2018 Jun; 24(11):2678-2687. PubMed ID: 29511030
[No Abstract] [Full Text] [Related]
[Next] [New Search]